| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 21.681 | - | - | 10.549 | 12.652 | 22.426 | 46.242 | 34.976 | 43.627 | 43.615 |
| Total Income - EUR | 21.682 | - | - | 10.549 | 12.652 | 22.426 | 47.191 | 91.527 | 92.162 | 91.890 |
| Total Expenses - EUR | 24.789 | - | - | 17.393 | 16.022 | 15.298 | 23.187 | 40.111 | 43.838 | 46.958 |
| Gross Profit/Loss - EUR | -3.107 | - | - | -6.844 | -3.370 | 7.129 | 24.004 | 51.416 | 48.324 | 44.931 |
| Net Profit/Loss - EUR | -3.757 | - | - | -6.844 | -3.496 | 6.913 | 23.625 | 51.090 | 47.904 | 44.501 |
| Employees | 1 | - | - | 1 | 1 | 1 | 1 | 2 | 3 | 3 |
Check the financial reports for the company - Medicavet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.677 | - | - | 11.617 | 8.017 | 4.940 | 11.336 | 6.199 | 3.406 | 1.389 |
| Current Assets | 8.785 | - | - | 1.360 | 479 | 7.938 | 19.503 | 71.037 | 70.451 | 67.523 |
| Inventories | 2.234 | - | - | 260 | 197 | 98 | 257 | 3.051 | 3.757 | 3.453 |
| Receivables | 0 | - | - | 30 | 25 | 4.135 | 6.992 | 49.530 | 45.093 | 9.947 |
| Cash | 6.551 | - | - | 1.070 | 257 | 3.705 | 12.253 | 18.455 | 21.601 | 54.123 |
| Shareholders Funds | 10.157 | - | - | 2.367 | -1.176 | 5.760 | 29.256 | 73.666 | 70.411 | 66.883 |
| Social Capital | 17.773 | - | - | 16.976 | 16.648 | 16.332 | 15.970 | 16.019 | 15.971 | 15.882 |
| Debts | 1.306 | - | - | 10.611 | 9.672 | 7.117 | 1.582 | 3.570 | 3.447 | 2.029 |
| Income in Advance | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Medicavet Srl